Profile picture

Doctor David Nagy

Semmelweis University Heart and Vascular Center, Budapest (Hungary)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

The effect of ARNI and SGLT2i therapies on the inflammasome pathway in myocardial heart transplantation biobank samples.
Presentation
The effect of ARNI and SGLT2i therapies on the inflammasome pathway in myocardial heart transplantation biobank samples.
The effect of novel heart failure pharmacotherapies on myocardial fibrosis and inflammasome pathway proteins in myocardial samples of heart failure patients undergoing heart transplantation
Presentation
The effect of novel heart failure pharmacotherapies on myocardial fibrosis and inflammasome pathway proteins in myocardial samples of heart failure patients undergoing heart transplantation
The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation
Presentation
The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation
Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation
Presentation
Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation
The anti-remodeling effect of sacubitril/valsartan in myocardial samples of end-stage heart failure patients
Presentation
The anti-remodeling effect of sacubitril/valsartan in myocardial samples of end-stage heart failure patients

ESC 365 is supported by